Publications
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , Molecular Cancer, vol. 23, no. 1, 156. https://doi.org/10.1186/s12943-024-02060-5
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy;
Butner, JD, Dogra, P, Chung, C, Koay, EJ, Welsh, JW, Hong, DS, Cristini, V & Wang, Z 2024, , npj Systems Biology and Applications, vol. 10, no. 1, 88, pp. 88. https://doi.org/10.1038/s41540-024-00415-8
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , Molecular Cancer, vol. 23, no. 1, pp. 156. https://doi.org/10.1186/s12943-024-02060-5
Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery;
Tijani, AO, Connors, D, Schiavone, C, Peláez, MJ, Dogra, P & Puri, A 2024, , International Journal of Pharmaceutics, vol. 660, 124289. https://doi.org/10.1016/j.ijpharm.2024.124289
Clinical Validation of Mathematically Derived Early Tumor Dynamics for Solid Tumors in Response to Durvalumab;
Li, Q, Cristini, V, Gupta, A, Achour, I, Barrett, JC & Koay, EJ 2024, , JCO clinical cancer informatics, vol. 8, 00074, pp. e2300254. https://doi.org/10.1200/CCI.23.00254
Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery;
Tijani, AO, Connors, D, Schiavone, C, Peláez, MJ, Dogra, P & Puri, A 2024, , International Journal of Pharmaceutics, vol. 660, 124289, pp. 124289. https://doi.org/10.1016/j.ijpharm.2024.124289
Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy;
Butner, J, Dogra, P, Chung, C, Koay, E, Welsh, J, Hong, D, Cristini, V & Wang, Z 2024, , Research square. https://doi.org/10.21203/rs.3.rs-4151883/v1
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , medRxiv. https://doi.org/10.1101/2024.03.14.24304306
Hybrid Cellular Automata Modeling Reveals the Effects of Glucose Gradients on Tumour Spheroid Growth;
Messina, L, Ferraro, R, Peláez, MJ, Wang, Z, Cristini, V, Dogra, P & Caserta, S 2023, , Cancers, vol. 15, no. 23, 5660. https://doi.org/10.3390/cancers15235660
Hybrid Cellular Automata Modeling Reveals the Effects of Glucose Gradients on Tumour Spheroid Growth;
Messina, L, Ferraro, R, Peláez, MJ, Wang, Z, Cristini, V, Dogra, P & Caserta, S 2023, , Cancers, vol. 15, no. 23, 5660. https://doi.org/10.3390/cancers15235660